New York State Common Retirement Fund’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.27M Sell
513,904
-8,100
-2% -$83.9K 0.01% 1083
2025
Q4
$6.45M Hold
522,004
0.01% 930
2025
Q3
$4.6M Buy
522,004
+128,429
+33% +$999K 0.01% 1099
2025
Q2
$2.51M Buy
393,575
+18,541
+5% +$106K ﹤0.01% 1330
2025
Q1
$1.82M Buy
375,034
+68,748
+22% +$569K ﹤0.01% 1413
2024
Q4
$2.93M Buy
306,286
+90,113
+42% +$827K ﹤0.01% 1284
2024
Q3
$1.81M Buy
216,173
+78,442
+57% +$713K ﹤0.01% 1443
2024
Q2
$939K Sell
137,731
-15,673
-10% -$67.4K ﹤0.01% 1787
2024
Q1
$388K Hold
153,404
﹤0.01% 2172
2023
Q4
$368K Sell
153,404
-120
-0.1% -$282 ﹤0.01% 2219
2023
Q3
$522K Sell
153,524
-2,018
-1% -$11.2K ﹤0.01% 2041
2023
Q2
$1.14M Sell
155,542
-27,230
-15% -$253K ﹤0.01% 1714
2023
Q1
$1.89M Sell
182,772
-30,465
-14% -$368K ﹤0.01% 1568
2022
Q4
$2.52M Buy
213,237
+26,561
+14% +$411K ﹤0.01% 1520
2022
Q3
$3.92M Sell
186,676
-301,448
-62% -$8.39M 0.01% 1281
2022
Q2
$15.2M Sell
488,124
-24,220
-5% -$827K 0.02% 678
2022
Q1
$21M Buy
512,344
+11,710
+2% +$516K 0.02% 607
2021
Q4
$21.8M Sell
500,634
-53,487
-10% -$2.42M 0.02% 624
2021
Q3
$27.7M Buy
554,121
+45,692
+9% +$2.77M 0.03% 518
2021
Q2
$32M Buy
508,429
+134,354
+36% +$8.63M 0.03% 475
2021
Q1
$34.8M Buy
374,075
+8,279
+2% +$848K 0.04% 431
2020
Q4
$32.8M Buy
365,796
+24,735
+7% +$2.27M 0.04% 450
2020
Q3
$35.2M Buy
341,061
+2,046
+0.6% +$221K 0.04% 386
2020
Q2
$26.8M Sell
339,015
-263,166
-44% -$19.6M 0.03% 481
2020
Q1
$34.8M Buy
602,181
+161,843
+37% +$9.33M 0.05% 325
2019
Q4
$23.8M Buy
440,338
+53,655
+14% +$2.91M 0.03% 584
2019
Q3
$20.2M Sell
386,683
-10,851
-3% -$506K 0.03% 622
2019
Q2
$19.2M Buy
397,534
+283,165
+248% +$13.6M 0.02% 674
2019
Q1
$5.78M Buy
114,369
+37,551
+49% +$2.22M 0.01% 1183
2018
Q4
$4.55M Sell
76,818
-7,500
-9% -$483K 0.01% 1226
2018
Q3
$5.55M Sell
84,318
-7,686
-8% -$448K 0.01% 1220
2018
Q2
$4.64M Buy
92,004
+15,123
+20% +$788K 0.01% 1294
2018
Q1
$4.05M Buy
76,881
+19,371
+34% +$965K 0.01% 1304
2017
Q4
$2.67M Sell
57,510
-3,656
-6% -$154K ﹤0.01% 1494
2017
Q3
$2.47M Sell
61,166
-37,604
-38% -$1.36M ﹤0.01% 1517
2017
Q2
$3.35M Buy
98,770
+12,380
+14% +$382K ﹤0.01% 1438
2017
Q1
$2.51M Sell
86,390
-42,652
-33% -$1.3M ﹤0.01% 1535
2016
Q4
$4.24M Buy
129,042
+19,330
+18% +$580K 0.01% 1315
2016
Q3
$3.46M Buy
109,712
+35,707
+48% +$1.04M 0.01% 1382
2016
Q2
$2.08M Buy
74,005
+9,089
+14% +$356K ﹤0.01% 1601
2016
Q1
$2.36M Buy
64,916
+1,400
+2% +$49.5K ﹤0.01% 1511
2015
Q4
$2.54M Sell
63,516
-6,400
-9% -$223K ﹤0.01% 1514
2015
Q3
$1.99M Sell
69,916
-69,790
-50% -$2.3M ﹤0.01% 1598
2015
Q2
$4.6M Buy
139,706
+62,799
+82% +$1.95M 0.01% 1401
2015
Q1
$2.21M Buy
76,907
+16,107
+26% +$462K ﹤0.01% 1610
2014
Q4
$1.66M Hold
60,800
﹤0.01% 1684
2014
Q3
$1.3M Sell
60,800
-8,700
-13% -$199K ﹤0.01% 1783
2014
Q2
$1.56M Buy
69,500
+1,000
+1% +$23.3K ﹤0.01% 1754
2014
Q1
$1.73M Hold
68,500
﹤0.01% 1693
2013
Q4
$1.57M Buy
68,500
+9,100
+15% +$190K ﹤0.01% 1703
2013
Q3
$1.13M Hold
59,400
﹤0.01% 1732
2013
Q2
$857K Buy
+59,400
New +$860K ﹤0.01% 1665

Other funds holding EBS